Cellebrite DI Ltd. Stock-Based Compensation
Cellebrite DI Ltd. (CLBT) reported Stock-Based Compensation of $44.89 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-03-03
| Period end | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|
| 2025-12-31 | $44.89M 20-F · filed 2026-03-03 | |
| 2025-06-30 | $17.59M 6-K · filed 2025-08-14 | |
| 2024-12-31 | $30.57M 20-F · filed 2026-03-03 | |
| 2024-06-30 | $12.25M 6-K · filed 2025-08-14 | |
| 2023-12-31 | $19.00M 20-F · filed 2026-03-03 | |
| 2023-06-30 | $9.06M 6-K · filed 2024-08-15 | |
| 2022-12-31 | $13.71M 20-F · filed 2025-03-18 | |
| 2022-06-30 | $6.46M 6-K · filed 2023-09-01 | |
| 2021-12-31 | $6.48M 20-F · filed 2024-03-21 | |
| 2021-06-30 | $3.40M 6-K · filed 2022-09-13 | |
| 2020-12-31 | $7.27M 20-F · filed 2023-04-27 | |
| 2019-12-31 | $12.76M 20-F · filed 2022-03-29 |